Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection.
Shaohui WangXianghong JuJoshua HeulerKe-Shan ZhangZhibian DuanHiran Malinda Lamabadu Warnakulasuriya PatabendigeSong ZhaoXingmin SunPublished in: Infection and immunity (2023)
Bacterial flagella are involved in infection through their roles in host cell adhesion, cell invasion, auto-agglutination, colonization, the formation of biofilms, and the regulation and secretion of nonflagellar bacterial proteins that are involved in the virulence process. In this study, we constructed a fusion protein vaccine (FliCD) containing the Clostridioides difficile flagellar proteins FliC and FliD. The immunization of mice with FliCD induced potent IgG and IgA antibody responses against FliCD, protected mice against C. difficile infection (CDI), and decreased the C. difficile spore and toxin levels in the feces after infection. Additionally, the anti-FliCD serum inhibited the binding of C. difficile vegetative cells to HCT8 cells. These results suggest that FliCD may represent an effective vaccine candidate against CDI.
Keyphrases
- clostridium difficile
- induced apoptosis
- cell cycle arrest
- escherichia coli
- high fat diet induced
- cell adhesion
- pseudomonas aeruginosa
- staphylococcus aureus
- cell death
- wastewater treatment
- signaling pathway
- oxidative stress
- metabolic syndrome
- diabetic rats
- wild type
- cell proliferation
- transcription factor
- drug induced
- cell free